| Literature DB >> 23585186 |
Sandrine Chamayou1, Pasquale Patrizio, Giorgia Storaci, Venera Tomaselli, Carmelita Alecci, Carmen Ragolia, Claudia Crescenzo, Antonino Guglielmino.
Abstract
PURPOSE: Embryo kinetics analysis is an emerging tool for selecting embryo(s) for transfer. The aim of the present study was to determine morphokinetic parameters easily usable in the laboratory and predictive of embryo development and, most importantly, of embryo competence in producing a clinical pregnancy after day 5 transfer.Entities:
Mesh:
Year: 2013 PMID: 23585186 PMCID: PMC3663978 DOI: 10.1007/s10815-013-9992-2
Source DB: PubMed Journal: J Assist Reprod Genet ISSN: 1058-0468 Impact factor: 3.412
Fig. 1Morphokinetic parameters from t0 to tEB (2PN: two pronuclei; 1C: 1 cell-stage,…, 9+: 9 cell-stage or more separated cells by individual membranes, M:morula, B:Blastocyst, EB: expanded blastocyst)
Embryo kinetic data from groups A-Imp, A-NU and B. All data are expressed in hours and fractions on an hour
| Group A-Imp | Group A-NU | Group B | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | mean | SD | median | Intervals | n | Mean | SD | median | Intervals | n | mean | SD | median | Intervals | |
| tF | 72 | 8.4 | 2.4 | 7.9 | 4.4;14.6 | 66 | 8.2 | 1.9 | 7.5 | 5.4;13.1 | 106 | 8.2 | 1.9 | 8.4 | 4.4;15.1 |
| tC | 72 | 23.5 | 3.0 | 23 | 17.4;30.2 | 66 | 25.5 | 4.7 | 25.7 | 17.5;37.5 | 106 | 23.9 | 3.8 | 22.9 | 18.4;39.1 |
| t1 | 72 |
| 2.9 | 23.6 | 18.4;30.9 | 66 |
| 4.9 | 26.1 | 18.0;41.0 | 106 | 24.4 | 4.0 | 23.5 | 18.7;40.4 |
| t2 | 72 |
| 3.2 | 26.1 | 21.4;34.8 | 66 |
| 6.8 | 29.0 | 20.4;56.3 | 106 | 27 | 4.0 | 26 | 21.7;43.4 |
| t3 | 72 | 38.3 | 4.3 | 38.4 | 27.8;47.8 | 66 | 38.9 | 8.1 | 40.1 | 28.8;58.9 | 106 | 38.8 | 4.9 | 37.7 | 33.4;57.5 |
| t4 | 72 |
| 5.7 | 39 | 33.1;57.2 | 62 |
| 7.4 | 41.2 | 29.1;59.1 | 106 | 40.5 | 5.0 | 39.5 | 34.4;58.8 |
| t5 | 72 | 53 | 6.0 | 53.1 | 37.5;67.0 | 62 | 53.5 | 10.4 | 53.5 | 33.1;91.8 | 106 | 52.7 | 7.5 | 50.7 | 40.0;84.0 |
| t6 | 72 | 54.3 | 5.8 | 53.5 | 46.1;73.5 | 57 | 58.2 | 10.9 | 55.7 | 41.8;96.5 | 106 | 54.5 | 8.2 | 52.7 | 44.7;87.4 |
| t7 | 72 |
| 8.6 | 55.1 | 46.1;82.5 | 55 |
| 11.1 | 58.2 | 46.4;98.5 | 106 | 57.6 | 9.8 | 54.8 | 46.7;95.3 |
| t8 | 72 |
| 10.8 | 57.3 | 46.4;97.8 | 53 |
| 15.6 | 60.7 | 47.3;124.6 | 106 | 60.8 | 11.5 | 58.1 | 47.4;107.0 |
| t9 | 72 | 77 | 8.5 | 77 | 57.6;98.8 | 43 | 72.6 | 10.8 | 74.6 | 49.0;91.8 | 106 | 76.5 | 11.3 | 75 | 53.7;110.7 |
| tM | 72 | 86 | 9.1 | 85.6 | 57.6;102.8 | 43 | 83.9* | 13.0 | 84.5 | 49.5;111.8 | 96 | 84.4 | 11.4 | 83.2 | 59.5;114.4 |
| tB | 65 | 104.5 | 6.4 | 103.6 | 94.6;117.8 | 7 | 108.5* | 6.5 | 106.7 | 102.9;117.8 | 54 | 105.2 | 8.6 | 107.5 | 88.6;116.2 |
| tEB | 43 | 111.7 | 3.9 | 112.9 | 103.6;117.8 | 0 | − | − | − | 20 | 110.5 | 6.2 | 113.2 | 98.3;120.1 | |
| tC-tF | 72 |
| 3.3 | 14.7 | 7.7;22.9 | 66 |
| 5.3 | 17.6 | 0.3;30.0 | 106 | 15.7 | 3.5 | 15 | 11.0;29.3 |
| cc2 | 72 | 11.4 | 2.5 | 12.0 | 1.3;14.7 | 66 | 11.9 | 8.2 | 12.0 | 0;17.0 | 106 | 11.8 | 2.0 | 11.9 | 0;15.1 |
| cc3 | 72 | 14.7 | 2.7 |
| 9.7;21.0 | 62 | 16.4 | 6.4 | 15.1 | 0;35.5 | 106 | 13.8 | 3.7 |
| 3.3;32.5 |
| cc4 | 72 | 24 | 4.9 | 24.3 | 4.3;31.8 | 45 | 23.2 | 10.1 | 22.2 | 0;37.1 | 95 | 23.8 | 6.5 | 23.6 | 4.0;43.2 |
| s2 | 72 | 2.0 | 3.8 | 0.5 | 0;15.7 | 62 | 4.7 | 4.1 | 1.0 | 0;17.6 | 106 | 1.7 | 2.9 | 0.7 | 0;13.5 |
| s3 | 72 |
| 8.7 | 4.5 | 0.7;30.8 | 53 |
| 11.3 | 8.9 | 0;47.8 | 103 | 8.1 | 7.7 | 5.2 | 0;30.4 |
*abnormal morulas or blastocysts as described in the text
Statistical analysis comparing the groups A-Imp with A-NU and B
| Groups A-Imp and B | Groups AImp and A-NU | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| tF | 0.202 | 0.58 | 0.157 | 0.076 | ||
| tC | 0.881 | 0.414 | 0.026 | 0.531 | ||
| t1 | 0.694 | 0.580 | 0.005 |
| ||
| t2 | 0.778 | 0.782 | 0.012 |
| ||
| t3 | 0.366 | 0.458 | 0.090 | 0.063 | ||
| t4 | 0.665 | 0.825 | 0.003 | 0.035 | ||
| t5 | 0.005 | − | 0.106 | 0.593 | 0.386 | |
| t6 | 0.310 | 0.856 | 0.017 | 0.062 | ||
| t7 | 0.584 | 0.894 | 0.006 |
| ||
| t8 | 0.599 | 0.922 | 0.023 |
| ||
| t9 | 0.190 | 0.771 | 0.107 | 0.178 | ||
| tM | 0.167 | 0.343 | 0.503 | 0.301 | ||
| tB | 0.074 | 0.602 | 0.088 | 0.095 | ||
| tEB | 0.621 | 0.368 | ||||
| tC-tF | 0.306 | 0.238 | 0.016 |
| ||
| cc2 | 0.423 | 0.268 | 0.294 | 0.224 | ||
| cc3 | 0.001 | − |
| 0.169 | 0.610 | |
| cc4 | 0.54 | 0.846 | 0.012 | 0.070 | ||
| s2 | 0.016 | − | 0.100 | 0.193 | 0.628 | |
| s3 | 0.092 | 0.902 | 0.001 |
| ||
DS standard deviation; p1: Kolmogorov-Smirnov test; p2: ANOVA test; p3: Kruskall-Wallis test
Fig. 2Embryonic kinetic parameters determining the capacity of an embryo to become a viable embryo on the fifth day of in vitro culture (group A-Imp: green) compared with embryos with impaired development (group A-NU : red). The kinetic parameters are expressed in hour and fraction of an hour
Fig. 3CC3 value of competent day 5 embryo to implant (Group A-Imp: Green) and embryos that fail to implant if transferred on day 5 (Group B: Orange). The kinetic parameters are expressed in hour and fraction of an hour
Comparison of our data and data in the literature
| Our data | Azzarello et al. [ | Ciray et al. [ | Meseguer et al. [ | Dal Canto et al. [ | Kirkegaard et al. [ | |||
|---|---|---|---|---|---|---|---|---|
| MKP | IVD/IMP* | IMP | IMP | IMP | IVD | IMP | IVD | |
| Type of data | Mean/Median (cc3) | Inferior limit | Mean | Mean | Mean | Mean | Mean | Median (95 % CI) |
| n emb. | 72 | 37 | 9 | 9 | 61 | 93 | 19 | 53 |
| tC-tF |
| − | − | − | − | − | − | |
| t1 |
|
| − | − | − | − | − | |
| t2 |
| − |
|
| 25.6 ± 2.2 | 27.9 ± 4.1 | 26.1 (25.2–26.9) | |
| t3 | 38.3 (27.8–47.8) | − | 35.7 ± 5.1 | 40.1 ± 4.1 | 37.4 ± 2.8 | 37.9 ± 4.6 | 35.7 (34.3–37.3) | |
| t4 |
| − | 36.6 ± 4.3 | 41.4 ± 4.5 | 38.2 ± 3.0 | 40.2 ± 5.8 | 37.6 (35.9–39.3) | |
| t5 | 53.0 (37.5–67.0) | − | 47.4 ± 7.9 | 53.9 ± 6.0 |
| 50.2 ± 6.7 | 49.4 ± 4.9 | 49.6 (47.3–52.0) |
| t6 | 54.3 (46.1–73.5) | − | − | − | − | 53.9 ± 7.6 | 52.4 (50.1–54.9) | |
| t7 |
| − | − | − | − |
| 58.0 (55.5–60.5) | |
| t8 |
| − | − | − | − |
|
| 60.5 (57.8–63.4) |
| cc2 | 11.4 (1.3–14.7) | − | 11.1 ± 2.4 | 12.2 ± 1.1 |
| 10.6 ± 1.8 | − | |
| cc3 |
| − | − | − | − | − | − | |
| s2 | 2.0 (0–15.7) | − | 0.9 ± 1.5 | 1.2 ± 1.3 |
| 2.3 ± 3.6 | − | |
| s3 |
| − | − | − | − |
| − | |
| CO2 % | 5 | 5.5 | 6 | 6 | 5 | 6 | 6 | |
| O2 % | 5 | 5 | 5 | 5 | 20 | 5 | 20 | |
| Medium | SAGE | COOK | Irvine (single) | Irvine (Seq) | SAGE | Origio | COOK | |
| Day of transfer | 5 | 2 | 4 | 4 | 3 | 3 | − | |
IVD in vitro development until day 5; Single single step medium; Seq sequential medium
All data are expressed in hour and fraction of an hour. The significant data are in bold